menometrorrhagia
Showing 1 - 25 of 141
Menorrhagia Trial in Bron (Use of the Lina LibrataTM)
Recruiting
- Menorrhagia
- Use of the Lina LibrataTM
-
Bron, FranceHospices Civils de Lyon
Jan 4, 2023
Abnormal Uterine Bleeding, Menorrhagia; Postmenopausal, Metrorrhagia Trial in Sousse (Tea infusion)
Completed
- Abnormal Uterine Bleeding
- +4 more
- Tea infusion
-
Sousse, Tunisiafaculty of medicine Sousse
Jun 4, 2022
Epilepsy, Complex Partial Trial in United States (ganaxolone)
Completed
- Epilepsy, Complex Partial
-
Los Angeles, California
- +6 more
Aug 13, 2022
Microbiome, Recurrent Pregnancy Loss Trial in Ashdod (coulture)
Not yet recruiting
- Microbiome
- Recurrent Pregnancy Loss
- coulture
-
Ashdod, IsraelAssuta Ashdod University Hospital
Nov 3, 2022
Time Between Hysterectomy and Resumption of Sexual Relations, Sexual Function Trial (Recommended time after hysterectomy)
Not yet recruiting
- Time Between Hysterectomy and Resumption of Sexual Relations
- Sexual Function
- Recommended time after hysterectomy
- (no location specified)
Feb 4, 2023
Mild and Moderate Iron-deficiency Anaemia Trial in Russian Federation (Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg
Completed
- Mild and Moderate Iron-deficiency Anaemia
- Ferrum Lek® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Lek d.d., Slovenia)
- MALTOFER® (iron (III) hydroxide polymaltosate), 100 mg chewable tablets (Vifor S.A., Switzerland)
-
Krasnogorsk, Russian Federation
- +17 more
Jun 18, 2021
ESI-related Bleeding Trial in Rochester (Doxycycline, Placebo)
Completed
- ESI-related Bleeding
- Doxycycline
- Placebo
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 6, 2021
Study About Patients Using Copper Intrauterine Device
Completed
- Copper Intrauterine Device Induced Bleeding
-
Cairo, Shoubra, EgyptShoubra Maternity Hospital
Dec 3, 2020
Fertility After Uterine Artery Embolization
Not yet recruiting
- Fertility Disorders
- +3 more
- Retrospective data collection
- Phone interview
-
Paris, FranceHôpital Européen Georges Pompidou
Feb 28, 2022
Uterine Fibroid, Myoma;Uterus Trial in Monserrato (hysteroscopy)
Recruiting
- Uterine Fibroid
- Myoma;Uterus
- hysteroscopy
-
Monserrato, Cagliari, ItalyUniversity of Cagliari,Obstetrics and Gynecological Department,
Feb 10, 2021
Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein Trial in Taiwan, United States (Zilver Vena Venous Self-Expanding
Completed
- Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein
- Zilver Vena Venous Self-Expanding Stent
-
Birmingham, Alabama
- +29 more
Mar 12, 2021
Multiple Sclerosis Trial in Worldwide (ofatumumab with PRF, ofatumumab with AI)
Completed
- Multiple Sclerosis
- ofatumumab with PRF
- ofatumumab with AI
-
Fullerton, California
- +40 more
Oct 7, 2021
Epilepsy Trial in Worldwide (Brivaracetam (ucb 34714))
Completed
- Epilepsy
- Brivaracetam (ucb 34714)
-
San Francisco, California
- +152 more
Aug 16, 2021
Pulmonary Arterial Hypertension Trial in Worldwide (Macitentan)
Completed
- Pulmonary Arterial Hypertension
-
Birmingham, Alabama
- +157 more
Jan 19, 2022
Relapsing Multiple Sclerosis Trial in Worldwide (Laquinimod)
Terminated
- Relapsing Multiple Sclerosis
-
Phoenix, Arizona
- +134 more
Dec 7, 2021
Pulmonary Arterial Hypertension Trial in Worldwide (Riociguat (Adempas, BAY63-2521), Sildenafil, Tadalafil)
Completed
- Pulmonary Arterial Hypertension
- Riociguat (Adempas, BAY63-2521)
- +2 more
-
Phoenix, Arizona
- +80 more
Feb 3, 2021
Relapsing Multiple Sclerosis Trial in Worldwide (Ozanimod, Placebo)
Migraine Prophylaxis Trial in Worldwide (Fremanezumab, Placebo)
Non-alcoholic Steatohepatitis, Fatty Liver, Fibrosis, Liver Trial in San Antonio (Nitazoxanide 500mg BID)
Completed
- Non-alcoholic Steatohepatitis
- +3 more
- Nitazoxanide 500mg BID
-
San Antonio, TexasPinnacle Clinical Research
Jun 29, 2022